Gene · 3675
Papers2,788
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,788
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Robust and efficient annotation of cell states through gene signature scoring. | Genome Res | 2026 | 41708334 | PubTator, text mining | PubMed |
| Extracellular matrix sensing regulates intratumoral heterogeneity of autophagic flux. | Cell | 2026 | 41702399 | PubTator, text mining | PubMed |
| Bridging cancer cell-intrinsic driver genes and -extrinsic cell-cell communication with Driver2Comm. | PLoS Comput Biol | 2026 | 41701761 | PubTator, text mining | PubMed |
| Identification of Basement Membrane-Related Biomarkers in the Progression of Cutaneous Squamous Cell Carcinoma. | Int J Mol Sci | 2026 | 41683815 | PubTator, text mining | PubMed |
| SH3BP5L triggers the RAB11A-regulated integrin recycling network implicated in breast cancer metastasis. | J Clin Invest | 2026 | 41623179 | PubTator, text mining | PubMed |
| Pathogenomic analysis reveals clinically relevant epithelial-mesenchymal plasticity in esophageal squamous cell carcinoma. | Theranostics | 2026 | 41608573 | PubTator, text mining | PubMed |
| A Chemoenzymatic Method To Systematically Quantify Core Fucosylation Stoichiometry of Glycoproteins and Reveal Its Roles in EMT and Embryonic Development. | Anal Chem | 2026 | 41553297 | PubTator, text mining | PubMed |
| Focal Adhesion and Cancer Cell Cycle-Associated Resistance. | ACS Omega | 2026 | 41552449 | PubTator, text mining | PubMed |
| Apicobasal Polarity Protein PARD3 Plays an Essential Role in Human Corneal Epithelial Cells. | Invest Ophthalmol Vis Sci | 2026 | 41533900 | PubTator, text mining | PubMed |
| A novel anoikis resistance-associated gene model for prognostic prediction and immune microenvironment characterization in lung squamous cell carcinoma. | Discov Oncol | 2026 | 41530460 | PubTator, text mining | PubMed |
| Identification of Potential Focal Segmental Glomerulosclerosis (FSGS) Through Evaluation of Parietal Epithelial Cells Status Changes Using Integrin α3 Immunostaining. | Lab Invest | 2026 | 41456713 | PubTator, text mining | PubMed |
| Epithelial-Mesenchymal Transition and Stress Adaptations Underlie Yttrium-90 Resistance in Liver Cancer Cell Lines. | Cancer Res Commun | 2026 | 41411069 | PubTator, text mining | PubMed |
| Targeting Interactions Between Siglec-10 and α3β1 Integrin Enhances Macrophage-Mediated Phagocytosis of Pancreatic Cancer. | Cancer Res | 2026 | 41182080 | PubTator, text mining | PubMed |
| Isolation and Characterization of Meniscus Progenitor Cells From Rat, Rabbit, Goat, and Human. | Cartilage | 2026 | 39058020 | PubTator, text mining | PubMed |
| A comprehensive review on seroepidemiology and molecular epidemiology of hepatitis E Virus in Iran. | Gastroenterol Hepatol Bed Bench | 2025 | 41777923 | PubTator, text mining | PubMed |
| A novel variant c.A527G in ITGB4 leads to autosomal dominant epidermolysis bullosa in China. | Front Med (Lausanne) | 2025 | 41728014 | PubTator, text mining | PubMed |
| Pan-cancer analysis of integrin alpha family and prognosis validation in head and neck squamous cell carcinoma. | Front Oncol | 2025 | 41602372 | PubTator, text mining | PubMed |
| Decoding anoikis-related genes in lung adenocarcinoma brainmetastasis via single-cell RNA sequencing: CD44-mediated functions. | BMC Cancer | 2025 | 41454310 | PubTator, text mining | PubMed |
| Autologous profiling reveals inter-patient heterogeneity in Vδ2+γδTIL responses to glioblastoma driven by extracellular matrix-BTN3A axis. | J Immunother Cancer | 2025 | 41407399 | PubTator, text mining | PubMed |
| Genetic and environmental factors associated with alteration of filtration slit proteins and their functions: a scoping review. | Front Nephrol | 2025 | 41368354 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3675/papers?page=3